nipradilol has been researched along with Low Tension Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araie, M; Kitazawa, Y; Ohashi, Y; Shirato, S; Yamazaki, Y | 1 |
| Araie, M; Kitazawa, Y; Matsumoto, C; Ohashi, Y; Shirato, S; Yamazaki, Y | 1 |
2 trial(s) available for nipradilol and Low Tension Glaucoma
| Article | Year |
|---|---|
Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.
Topics: Administration, Topical; Adult; Antihypertensive Agents; Disease Progression; Double-Blind Method; Female; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Middle Aged; Ophthalmic Solutions; Propanolamines; Timolol; Treatment Outcome; Vision Disorders; Visual Field Tests; Visual Fields | 2010 |
Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy.
Topics: Adrenergic beta-Antagonists; Disease Progression; Double-Blind Method; Female; Humans; Intraocular Pressure; Low Tension Glaucoma; Male; Middle Aged; Myopia; Ophthalmic Solutions; Prognosis; Propanolamines; Prospective Studies; Risk Factors; Timolol; Tonometry, Ocular; Vision Disorders; Visual Fields | 2012 |